Can Vagus Nerve Stimulation Help POTS? What the Research Shows So Far
A 2026 review of three small studies found ear-based vagus nerve stimulation lowered the heart rate jump on standing in POTS. What it showed and didn't.
Photo: Declan Sun / Unsplash
Can vagus nerve stimulation help POTS? It might help some people, but the research is still early. In 2026, a review found only three clinical studies of vagus nerve stimulation through the skin of the ear in POTS, with 105 patients between them. Across those studies, the stimulation lowered how much the heart rate jumped on standing. The studies were small and used different devices and schedules, so this is something to discuss with your doctor rather than an established treatment.
Why are vagus nerve devices for POTS getting so much attention?
POTS stands for postural orthostatic tachycardia syndrome. When you stand up, the autonomic nervous system usually tightens the blood vessels a little so blood still reaches your head. In POTS that adjustment doesn't happen the way it should, so the heart beats faster to make up for it. Lightheadedness, brain fog, and fatigue can come with the racing heart.
The vagus nerve is the main nerve of the parasympathetic nervous system, which is the branch that slows the heart and calms the body after a stress response. One small branch reaches the skin of the outer ear, and transcutaneous vagus nerve stimulation (tVNS) uses that branch. tVNS means a mild electrical current delivered through the skin, usually with a clip on the ear, with no surgery involved. Companies sell ear devices widely for stress and for dysautonomia. Dysautonomia is the umbrella term for problems with the autonomic nervous system. So patients want to know whether the research supports these devices for POTS.
What did the 2026 review look at?
Kshitiz Pandey and colleagues in Oklahoma searched five databases through March 2026 and found those three studies. The studies differed too much to combine, so the authors did a narrative synthesis instead of a meta-analysis. A narrative synthesis compares results study by study, whereas a meta-analysis pools them statistically.
What did it find?
The authors reported that tVNS consistently reduced orthostatic tachycardia, meaning the rise in heart rate on standing, and improved several measures of autonomic function. They also reported lower levels of GPCR autoantibodies and inflammatory markers. GPCR autoantibodies are antibodies the immune system makes against cell receptors, including ones that help control the heart and blood vessels. Symptoms improved in the two studies that reported them, and results lasted up to one to two years. The authors concluded that tVNS "may contribute to disease modification."
The trial led by Stavros Stavrakis compared active stimulation with a sham, which is a fake version of the treatment. Twenty-six women with POTS used an ear clip daily for two months. For 12 of them it went on the tragus (the small flap in front of the ear canal, which has vagus nerve fibers), and for 14 it went on the earlobe, which has none. The researchers didn't tell participants which site was active. After two months, heart rate rose by about 18 beats per minute on standing in the active group compared with about 32 with sham, so the active group's jump was a little over half the size. The active group also had lower activity of two autonomic autoantibodies and lower TNF-alpha, an inflammatory signal. Still, the overall autonomic symptom score didn't differ significantly between the two groups, which had 12 and 14 women at the start. In their limitations section, the authors wrote that the trial could not show tVNS improved how patients felt.
Dana Shiffer and colleagues in Milan took a narrower group: 22 people with hyperadrenergic POTS. That's the type with too much activity in the fight-or-flight branch of the nervous system. Everyone used the device at home daily for two weeks. Afterward, symptom scores were lower lying down and during a tilt test, and direct recordings of sympathetic nerve signals to the blood vessels were lower too. About two years after people stopped (the median), those who came back for a final visit still had a lower heart rate during the tilt and lower symptom scores than at the start. About a quarter of the 22 skipped that visit because they didn't want another nerve recording. There was no control group, though, and the authors acknowledged that they could not completely rule out placebo effects or symptoms improving on their own.
What hasn't been shown yet?
The trials are small: three studies with 105 people between them, and the Shiffer study had no comparison group at all. The authors worded disease modification as a possibility, and the review's abstract doesn't describe any study that measured whether the course of POTS itself changed.
There is also an open question about what "improving vagal tone" means. Heart rate variability (HRV) is the small beat-to-beat variation in heart rate, and researchers use part of HRV as a stand-in for vagus nerve activity. In a 2021 meta-analysis of 16 single-blind studies in healthy volunteers, Vinzent Wolf and colleagues found strong evidence that short-term (acute) ear stimulation does not change vagally mediated HRV compared with sham. Those were healthy people tested over the short term, so the finding is about a different group and setting. Still, an HRV number alone isn't a reliable marker of whether short-term stimulation had an effect.
Where does tVNS fit with the different types of POTS?
POTS can have more than one cause. The three main types are neuropathic POTS, where damage to small nerve fibers keeps the blood vessels from tightening; hyperadrenergic POTS; and hypovolemic POTS, where there isn't enough blood volume. Joint hypermobility, mast cell activation, adrenal issues, and autoimmune conditions can be part of the picture as well. A lot of POTS patients have a mix of types.
I'm trained in biofeedback, and I've seen people learn some conscious control over functions like hand temperature with enough practice. So I think nervous system work like biofeedback can help with dysautonomia, but it's one part of the picture rather than the whole of it. The studies above are still testing whether a vagus nerve device helps in the same way. Nervous system work makes the most sense to me when chronic stress has kept someone stuck in fight-or-flight, which can be part of hyperadrenergic POTS, and the Shiffer study did choose hyperadrenergic patients on purpose. If the adrenal glands have been over- or under-producing for a long time, though, that might need more than nervous system work. If the main problem is low blood volume, more fluid and salt is a much more direct approach. And if nerve damage, an autoimmune process, or inflammation after an infection is part of it, a calmer nervous system can't remove that cause on its own.
Bringing tVNS up with your doctor
It makes sense to talk tVNS over with your POTS doctor, particularly if you take heart rate or blood pressure medication, since the stimulation is meant to change heart rate too. Standing tests can vary from one day to the next, so I'd suggest keeping a diary of your standing heart rate and how you feel upright and bringing it to your next appointment.
If you want to see what your own heart rate does when you stand, The Home Stand Test is a free guide to doing the active stand test at home, what your heart rate numbers mean, and what to ask your doctor for.
FAQ
What is transcutaneous vagus nerve stimulation?
Transcutaneous vagus nerve stimulation, or tVNS, sends a mild electrical current through the skin to a branch of the vagus nerve, usually at the ear. It doesn't involve surgery. The vagus nerve is part of the parasympathetic nervous system, which slows the heart and calms the body after a stress response.
Does vagus nerve stimulation lower heart rate in POTS?
In the three small studies a 2026 review found, tVNS reduced the rise in heart rate on standing. In the sham-controlled trial led by Stavros Stavrakis, heart rate rose about 18 beats per minute on standing after two months of active stimulation, compared with about 32 with sham stimulation. Those studies included 105 people in total, so larger trials are still needed.
Does vagus nerve stimulation improve POTS symptoms?
The evidence on symptoms is mixed. The review reported that symptoms improved in the two studies that reported them. In the sham-controlled trial, though, the overall autonomic symptom score didn't differ significantly between the groups, which had 12 and 14 women at the start, and only the portion that includes sweating improved.
Is ear vagus nerve stimulation safe?
The sham-controlled trial reported no device-related side effects over two months. In the hyperadrenergic POTS study of 22 people, the side effects were minor and lasted less than three days: headaches or migraines, skin redness at the electrode, and trouble sleeping in three people each, plus diarrhea or tremor in two each and ringing in the ears in one. Stimulation can change heart rate, so it's important to talk with your doctor first, especially if you take heart rate or blood pressure medication.
Which type of POTS might respond best to vagus nerve stimulation?
Researchers haven't compared the types head to head yet. One of the three studies chose hyperadrenergic patients on purpose, since that type involves too much fight-or-flight activity. For POTS that comes mainly from low blood volume, more fluid and salt is a more direct approach.
References
- 1.
- 2.
- 3.
- 4.
